COMMUNIQUÉS West-GlobeNewswire

Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial

20/02/2025 - 22:00

Initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 study Positive results could support the initiation of a pivotal Phase 3 trial in patients in [...]

Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent

20/02/2025 - 22:00

This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and [...]

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

20/02/2025 - 22:01

LONDON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, February 25, 2025 at 8:30 a.m. Eastern [...]

Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

20/02/2025 - 22:01

Company to submit sNDA around the end of 1Q 2025 seeking traditional approval of FILSPARI ® (sparsentan) for FSGS Net product sales of FILSPARI totaled $50 million in 4Q 2024; $132 million for full year 2024 Net product [...]

Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025

20/02/2025 - 22:01

VANCOUVER, British Columbia and BOSTON, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]

Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders

20/02/2025 - 22:05

BALTIMORE, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has [...]

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

20/02/2025 - 22:05

Seasoned biotechnology CEO brings 25 years of strategic, operational and commercial expertise FOSTER CITY, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN [...]

Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

20/02/2025 - 22:05

HOLLISTER, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]

Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025

20/02/2025 - 22:05

NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel [...]

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

20/02/2025 - 22:05

MOUNTAIN VIEW, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it has completed the [...]

Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update

20/02/2025 - 22:05

- Management will hold a conference call on Thursday, February 27 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company [...]

Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences

20/02/2025 - 22:05

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in two upcoming investment bank conferences. The TD Cowen 45th Annual [...]

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

20/02/2025 - 22:05

SILVER SPRING, Md., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter and [...]

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

20/02/2025 - 22:05

DUBLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of [...]

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

20/02/2025 - 22:05

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients [...]

Phoenix Molecular Designs Dosed First Patient in Dauntless-1, a Phase 2 Clinical Trial of PMD-026 in Combination with Fulvestrant for RSK2-high Breast Cancer

20/02/2025 - 22:14

PMD-026 is a first-in-class and best-in-class pan-RSK inhibitor Favorable mPFS demonstrated in Phase 1/1b as a monotherapy in RSK2-high metastatic breast cancer patients. SAN DIEGO and VANCOUVER, British Columbia, Feb. [...]

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

20/02/2025 - 22:15

AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, [...]

AMN Healthcare Announces Fourth Quarter and Full Year 2024 Results

20/02/2025 - 22:15

Quarterly revenue of $735 million; GAAP loss of ($4.90)/share and adjusted EPS of $0.75 DALLAS, Feb. 20, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent [...]

Brighter Strides ABA Expands Services with New Clinic Opening in Maryland

20/02/2025 - 22:15

Providing Compassionate, Individualized ABA Therapy for Children with Autism Catonsville, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Brighter Strides ABA is proud to announce the grand opening of its newest clinic in [...]